SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-015331
Filing Date
2019-08-12
Accepted
2019-08-12 16:06:38
Documents
90
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_immucellcorporation.htm 10-Q 574829
2 CERTIFICATION f10q0619ex31_immucellcorp.htm EX-31 7112
3 CERTIFICATION f10q0619ex32_immucellcorp.htm EX-32 4222
  Complete submission text file 0001213900-19-015331.txt   4617152

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20190630.xml EX-101.INS 857944
5 XBRL SCHEMA FILE iccc-20190630.xsd EX-101.SCH 57372
6 XBRL CALCULATION FILE iccc-20190630_cal.xml EX-101.CAL 67645
7 XBRL DEFINITION FILE iccc-20190630_def.xml EX-101.DEF 188560
8 XBRL LABEL FILE iccc-20190630_lab.xml EX-101.LAB 419242
9 XBRL PRESENTATION FILE iccc-20190630_pre.xml EX-101.PRE 328050
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 191016553
SIC: 2835 In Vitro & In Vivo Diagnostic Substances